IL17A and infection: Importantly, in contrast to previous IAV/bacteria associations studied in the past, e.g., IAV/S.aureus; IAV/ S. pneumoniae, IAV pre-treatment did not condition the host to further PAO1 infection by restraining the IL-1β-IL-17 pathway (21, 22), and/or neutrophilic responses to bacteria (14–17).